How Childhood Cancer Research Is Advancing
Cancer doesn’t discriminate when it comes to who it affects and sometimes even otherwise healthy children can be diagnosed with the disease. Dr. Duane Mitchell, director of UF’s Preston A. Wells Jr. Center for Brain Tumor Therapy at the University of Florida and the co-director of the ReMission Alliance Against Brain Tumors, is among one […]
Air Purification Innovator, Molekule, Secures $58 Million in Series C Financing, Signaling Strong Investor Backing in the Fight for Clean Air
UF startup Molekule, the leader in reinventing air purification, announced it closed $58 million in Series C funding, led by RPS Ventures with participation from Founder’s Circle Capital. Existing investors included Foundry Group, Crosslink Capital, Uncork Capital, and TransLink Capital, along with new participation from Inventec Appliances Corp (IAC). This latest funding round is further […]
UF Health Opens New Center to Help Those With Autism and Neurodevelopmental Disabilities
University of Florida Health cut the ribbon on its new Center for Autism and Neurodevelopment, a multidisciplinary, collaborative facility that will provide specialized care and resources to children and adults with neurodevelopmental disorders and their families. “In and around the Gainesville community, parents have had barriers to obtaining diagnoses, assessments and appropriate treatments for their […]
Peerfit and BurnAlong Team Up to Combat the Growing Loneliness Epidemic
UF startup Peerfit, the digital health company that works with employers and insurance carriers to fully fund fitness experiences for their employees and members, announced that they will be partnering with fellow corporate wellness platform BurnAlong, in order to offer Peerfit members access to BurnAlong’s library of online video classes and social motivation features. This […]
Researchers Show What Drives a Novel, Ordered Assembly of Alternating Peptides
A team of researchers has verified that it is possible to engineer two-layered nanofibers consisting of an ordered row of alternating peptides, and has also determined what makes these peptides automatically assemble into this pattern. The fundamental discovery raises the possibility of creating a tailored “ABAB” peptide nanofibers with a variety of biomedical applications. The […]
Sid Martin Biotech Client Company Alchem Laboratories Expands Screening and Clinical Trial Manufacturing Capabilities
UF Innovate | Sid Martin Biotech, the leading biotechnology incubator at the University of Florida, is pleased to announce client company Alchem Laboratories Corporation, a contract research organization focused on process development and manufacturing of fine organic chemicals and drug substances, is expanding its screening and clinical trial capabilities. Merrie Shaw, Assistant Director of UF […]
Paul A. Gulig: Seek Facts on Vaccines From Reputable Sources
University of Florida researcher, Paul Gulig, Ph.D., an associate professor at the Department of Molecular Genetics and Microbiology, shares his opinion on The Gainesville Sun imploring readers to seek truth and fact from reputable sources when it comes to vaccines. Learn more about Paul A. Gulig: Seek Facts on Vaccines From Reputable Sources.
Twelve Leading Medical Centers Unite to Form Brain Tumor Research Collaborative
The UF Health-led ReMission Alliance Against Brain Tumors announced the names of twelve partner institutions from across the U.S. and Canada that are teaming up to develop novel treatments to vastly improve quality of life and long-term survival for patients fighting malignant brain tumors. Internationally recognized neuro-oncologists and brain tumor investigators from the twelve partner […]
Chlamydia’s Covert Reproduction
UF researchers have resolved a two-decade-old mystery centered upon how the bacteria chlamydia divide and reproduce. Newly published results from the lab of Anthony Maurelli, a microbiologist in UF’s College of Public Health and Health Professions and the Emerging Pathogens Institute (EPI), reveal that, how these parasitic pathogens replicate, diverges from a nearly universal norm. […]
AGTC Announces Completion of Enrollment in the Two Highest Dose Groups of Its Ongoing Phase 1/2 Clinical Trial in Patients With X-Linked Retinitis Pigmentosa
UF startup and UF Innovate | Sid Martin Biotech alum Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, announced that it has completed enrollment in the two highest dose groups of its Phase 1/2 clinical trial evaluating the safety […]